| Tripti Pawar Bds Msd Pllc | |
|
505 E Sunset Way Issaquah WA 98027-3438 | |
| (425) 392-0980 | |
| Not Available |
| Full Name | Tripti Pawar Bds Msd Pllc |
|---|---|
| Speciality | Clinic/Center |
| Location | 505 E Sunset Way, Issaquah, Washington |
| Authorized Official Name and Position | Tripti Pawar (OWNER) |
| Authorized Official Contact | 4253920980 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Tripti Pawar Bds Msd Pllc 505 E Sunset Way Issaquah WA 98027-3438 Ph: (425) 392-0980 | Tripti Pawar Bds Msd Pllc 505 E Sunset Way Issaquah WA 98027-3438 Ph: (425) 392-0980 |
| NPI Number | 1396492039 |
|---|---|
| Provider Enumeration Date | 03/02/2022 |
| Last Update Date | 03/02/2022 |
| Medicare PECOS PAC ID | 6103213418 |
|---|---|
| Medicare Enrollment ID | O20220504002502 |
News Archive
ADMEcell, announced that it has entered into an exclusive agreement with Advancell, Barcelona, Spain, to manufacture and distribute the CacoReady System for the North American market.
The good news is that people born as extremely low birth weight babies are less likely than others to have alcohol or substance use disorders as adults. The less encouraging news is that they may have a higher risk of other types of psychiatric problems.
The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.
› Verified 6 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396492039 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
| Provider Name | Tripti Pawar |
|---|---|
| Provider Type | Practitioner - Dentist |
| Provider Identifiers | NPI Number: 1013210939 PECOS PAC ID: 8022399880 Enrollment ID: I20220504002534 |
News Archive
ADMEcell, announced that it has entered into an exclusive agreement with Advancell, Barcelona, Spain, to manufacture and distribute the CacoReady System for the North American market.
The good news is that people born as extremely low birth weight babies are less likely than others to have alcohol or substance use disorders as adults. The less encouraging news is that they may have a higher risk of other types of psychiatric problems.
The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.
› Verified 6 days ago
News Archive
ADMEcell, announced that it has entered into an exclusive agreement with Advancell, Barcelona, Spain, to manufacture and distribute the CacoReady System for the North American market.
The good news is that people born as extremely low birth weight babies are less likely than others to have alcohol or substance use disorders as adults. The less encouraging news is that they may have a higher risk of other types of psychiatric problems.
The MDG Health Alliance, an innovative new private sector organization created and led by eminent business leaders to tackle urgent global health problems, was introduced today in the United States at the GBCHealth Conference.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that it has initiated patient enrollment in an open-label, multi-center Phase 1b clinical trial evaluating tivozanib in combination with oral capecitabine (Xeloda®) in patients with certain advanced solid tumors.
› Verified 6 days ago
Shadi Mohammadi Araghi Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 2520 Ne Park Drive, Suite C, Issaquah, WA 98029 Phone: 425-996-0457 | |
Apex Dental Care Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 22525 Se 64th Pl, Ste #170, Issaquah, WA 98027 Phone: 425-837-0711 | |
Tanner & Tanner, Pllc Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 22516 Se 64th Pl Ste 120, Issaquah, WA 98027 Phone: 425-392-8882 | |
Adara Surgical Institute Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 6505 226th Pl Se Ste 100, Issaquah, WA 98027 Phone: 425-332-5333 Fax: 425-332-5332 | |
Lake Sammamish Family Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 5712 E Lake Sammamish Pkwy Se, Ste 108, Issaquah, WA 98029 Phone: 425-392-3900 | |
Children's Dentistry Of Issaquah Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 710 Nw Juniper St, Suite 208, Issaquah, WA 98027 Phone: 425-837-0021 | |
Covington Comfort Dentistry Dental Clinic Medicare: Not Enrolled in Medicare Practice Location: 22525 Se 64th Pl, Ste #170, Issaquah, WA 98027 Phone: 425-837-0711 |